nimbolide has been researched along with Cancer of Prostate in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Dawood, M; Efferth, T; Huang, Q; Mahmoud, N; Ng, JPL; Ren, F; Wong, VKW | 1 |
Ahn, KS; Alharbi, SA; Chinnathambi, A; Deivasigamani, A; Hui, KM; Jung, YY; Mohan, CD; Rangappa, KS; Sethi, G; Zhang, J | 1 |
Arunakaran, J; Arunkumar, R; Brindha Mercy, A; Elumalai, P; Raja Singh, P; Senthilkumar, K; Sharmila, G; Sivakamasundari, V; Suganthapriya, E | 1 |
Ahn, KS; Arfuso, F; Deivasigamanim, A; Goh, BC; Hui, KM; Kim, C; Kumar, AP; Lim, LH; Samym, RP; Sethi, G; Shanmugam, MK; Siveen, KS; Wang, L; Zhang, J | 1 |
Arunakaran, J; Arunkumar, R; Balakrishnan, S; Priya, ES; Rajalakshmi, M; Sharmila, G; Singh, PR | 1 |
Arunakaran, J; Arunkumar, R; Balakrishnan, S; Raja Singh, P; Rajalakshmi, M; Sharmila, G; Sugantha Priya, E | 1 |
6 other study(ies) available for nimbolide and Cancer of Prostate
Article | Year |
---|---|
Nimbolide inhibits 2D and 3D prostate cancer cells migration, affects microtubules and angiogenesis and suppresses B-RAF/p.ERK-mediated in vivo tumor growth.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Humans; Limonins; Male; Mice; Microtubules; Prostatic Neoplasms | 2022 |
Nimbolide enhances the antitumor effect of docetaxel via abrogation of the NF-κB signaling pathway in prostate cancer preclinical models.
Topics: Cell Line, Tumor; DNA; Docetaxel; Humans; Limonins; Male; NF-kappa B; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Survivin | 2022 |
Anti-proliferative and apoptosis inducing effect of nimbolide by altering molecules involved in apoptosis and IGF signalling via PI3K/Akt in prostate cancer (PC-3) cell line.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA Fragmentation; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Limonins; Male; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Receptor, IGF Type 1; Signal Transduction; Somatomedins | 2014 |
Nimbolide-Induced Oxidative Stress Abrogates STAT3 Signaling Cascade and Inhibits Tumor Growth in Transgenic Adenocarcinoma of Mouse Prostate Model.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Drug Screening Assays, Antitumor; Humans; Limonins; Male; Mice; Mice, Transgenic; Neoplasms, Experimental; Oxidative Stress; Prostatic Neoplasms; Reactive Oxygen Species; Signal Transduction; STAT3 Transcription Factor | 2016 |
Nimbolide inhibits androgen independent prostate cancer cells survival and proliferation by modulating multiple pro-survival signaling pathways.
Topics: Androgens; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Limonins; Male; MAP Kinase Signaling System; Molecular Docking Simulation; Neoplasm Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Prostatic Neoplasms; Receptors, Tumor Necrosis Factor, Type I; RNA, Messenger; Signal Transduction; Tumor Necrosis Factor-alpha | 2016 |
Inhibition of cell survival and proliferation by nimbolide in human androgen-independent prostate cancer (PC-3) cells: involvement of the PI3K/Akt pathway.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Limonins; Male; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction | 2017 |